Management of opioid-induced constipation
- PMID: 11309211
- DOI: 10.1007/s11916-001-0037-7
Management of opioid-induced constipation
Abstract
Constipation is an expected side effect of opioid use and as such should be treated prophylactically. However, because it is often overlooked and under-appreciated it is one of the most common reasons patients avoid or abandon opioid use and, as a result, suffer pain needlessly. Thorough assessment, ongoing evaluation, and patient teaching are key factors in establishing an effective bowel regimen. A bowel clean-out is indicated for patients who have not had a bowel movement in more than 5 days. Once any impactions have been eliminated, a regular regimen of senna and docusate is recommended. Dietary modifications, fluids, and exercise are important but usually not sufficient to overcome opioid-induced constipation. Although many of the medicines that are used to treat pain and related symptoms come with a significant potential for distressing side effects, it is important to understand that most side effects, especially constipation, can be managed and quality of life can be preserved without sacrificing needed analgesia.
Similar articles
-
Management of Opioid-Induced Constipation in Hospice Patients.Am J Hosp Palliat Care. 2018 Feb;35(2):330-335. doi: 10.1177/1049909117705379. Epub 2017 Apr 20. Am J Hosp Palliat Care. 2018. PMID: 28423917
-
Assessing and managing opiate-induced constipation in adults with cancer.Cancer Control. 2004 May-Jun;11(3 Suppl):3-9. doi: 10.1177/10732748040110S302. Cancer Control. 2004. PMID: 15153834 Review. No abstract available.
-
Lubiprostone vs Senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial.World J Gastroenterol. 2014 Nov 21;20(43):16323-33. doi: 10.3748/wjg.v20.i43.16323. World J Gastroenterol. 2014. PMID: 25473191 Free PMC article. Clinical Trial.
-
Comparative effectiveness of senna to prevent problematic constipation in pediatric oncology patients receiving opioids: a multicenter study of clinically detailed administrative data.J Pain Symptom Manage. 2014 Aug;48(2):272-80. doi: 10.1016/j.jpainsymman.2013.09.009. Epub 2013 Dec 8. J Pain Symptom Manage. 2014. PMID: 24321507
-
Analgesia issues in palliative care: bone pain, controlled release opioids, managing opioid-induced constipation and nifedipine as an analgesic.J Pain Palliat Care Pharmacother. 2002;16(1):93-7. J Pain Palliat Care Pharmacother. 2002. PMID: 14650452 Review.
Cited by
-
Constipation in Chemotherapy Patients: A Diagnostic Accuracy Study.Asian Pac J Cancer Prev. 2021 Sep 1;22(9):3017-3021. doi: 10.31557/APJCP.2021.22.9.3017. Asian Pac J Cancer Prev. 2021. PMID: 34582674 Free PMC article.
-
Prevalence of opioid dispensings and concurrent gastrointestinal medications in Quebec.Pain Res Manag. 2008 Sep-Oct;13(5):395-400. doi: 10.1155/2008/435738. Pain Res Manag. 2008. PMID: 18958311 Free PMC article.
-
Slow-sustained delivery of naloxone reduces typical naloxone-induced precipitated opioid withdrawal effects in male morphine-dependent mice.J Neurosci Res. 2022 Jan;100(1):339-352. doi: 10.1002/jnr.24627. Epub 2020 Aug 8. J Neurosci Res. 2022. PMID: 32772457 Free PMC article.
-
Opioid-induced bowel dysfunction: pathophysiology and management.Drugs. 2012 Oct 1;72(14):1847-65. doi: 10.2165/11634970-000000000-00000. Drugs. 2012. PMID: 22950533 Review.
-
More opioids, more constipation? Evaluation of longitudinal total oral opioid consumption and self-reported constipation in patients with cancer.Support Care Cancer. 2020 Apr;28(4):1793-1797. doi: 10.1007/s00520-019-04996-7. Epub 2019 Jul 22. Support Care Cancer. 2020. PMID: 31332514
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical